Adaptive Strategies for Induced Birth
(IGNITE-IOL Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial is designed to investigate how best to support hospitals in improving induction management and clinical outcomes. The researchers will investigate an adaptive implementation strategy designed to support hospitals in increasing adherence to evidence-based practices for induction of labor.
Who Is on the Research Team?
Michelle Moniz, MD, MSc
Principal Investigator
University of Michigan
Are You a Good Fit for This Trial?
Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Stage 1: BASE
Hospitals receive BASE intervention to improve induction management
Stage 2: BASE + LEAD
All hospitals receive LEAD in addition to BASE to enhance adherence to evidence-based practices
Stage 3: BASE + LEAD + TEAM
Non-Top Performer hospitals receive TEAM in addition to BASE and LEAD; Top Performer hospitals continue with BASE + LEAD
Follow-up
Participants are monitored for adherence to evidence-based practices and clinical outcomes
What Are the Treatments Tested in This Trial?
Interventions
- BASE
- LEAD
- TEAM
How Is the Trial Designed?
4
Treatment groups
Experimental Treatment
Active Control
BASE + TEAM starts with BASE in Stage 1, continues BASE in Stage 2, continues BASE in Stage 3 for Top Performer hospitals, and adds TEAM in Stage 3 for non-Top Performer hospitals. This arm does not offer LEAD.
BASE + LEAD + TEAM starts with BASE in Stage 1. In Stage 2, all hospitals are offered LEAD. In Stage 3, Top Performing hospitals continue BASE + LEAD, while non-Top Performing hospitals step up to TEAM in addition to BASE and LEAD. This is considered the most intensive of the four embedded implementation strategies.
BASE + LEAD starts with BASE in Stage 1, adds LEAD in Stage 2 for all hospitals, and continues BASE + LEAD in Stage 3 for all hospitals. This arm does not offer TEAM.
The BASE only comparator (control arm) starts with BASE in Stage 1, continues with BASE in Stage 2, and continues with BASE in Stage 3, regardless of Top Performer status. The BASE only arm is defined as the hospitals that get solely BASE (and nothing more) for 30 months.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Michigan
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.